Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Turkiye Parazitol Derg ; 37(2): 135-8, 2013.
Artigo em Turco | MEDLINE | ID: mdl-23955912

RESUMO

Blastocystis hominis (B. hominis) is a parasite that often causes gastrointestinal symptoms in patients with immune deficiency and has a controversial pathogenicity in healthy people, although some symptoms are reported outside of the gastrointestinal system in healthy persons. Henoch-Schönlein Purpura (HSP) vasculitis is an acute autoimmune disease characterised by IgA storage of small vessels that is believed to include infectious factors in its aetiology. A 30-month follow-up with a boy diagnosed with HSP being treated with steroid therapy showed that he had recurrent symptoms within two days, and B. hominis was detected in the faecal analysis. His symptoms including rash, abdominal pain, and arthritis improved after treatment with steroid and co-trimaksazol. This paper is the first to present a case of HSP associated with B. hominis.


Assuntos
Infecções por Blastocystis/complicações , Blastocystis hominis/isolamento & purificação , Vasculite por IgA/complicações , Dor Abdominal , Infecções por Blastocystis/parasitologia , Pré-Escolar , Fezes/parasitologia , Gastroenteropatias/complicações , Gastroenteropatias/parasitologia , Humanos , Vasculite por IgA/diagnóstico , Vasculite por IgA/parasitologia , Masculino
2.
Klin Padiatr ; 222(7): 455-9, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20862630

RESUMO

BACKGROUND: Intrauterine growth restriction seems to be a risk factor for an aggravated course of secondary renal diseases in children. Catch-up growth after birth may play a critical role. We tested if there is an association between an aggravated course of nephritis in Henoch-Schönlein Purpura (PSHN) and low birth weight or early weight gain during infancy. PATIENTS: We retrospectively analysed the clinical course of 34 children with PSHN. METHODS: Patients were sorted according their birth weight standard deviation score (SDS) in tertiles. Early weight gain was defined as gain of weight standard deviation score >0.67 between birth and 2 years of age. RESULTS: Patients with higher birth weight needed Cyclophosphamide in a higher rate than low birth weight children. In the high weight gain group (SDS gain >0.67) 9 of the 11 patients compared to 7 of 22 patients in the low weight gain group (SDS gain <0.67) presented with arterial hypertension during the initial manifestation of PSH nephritis (p=0.01). Median systolic blood pressure SDS in the high weight gain group was 1.54 (-1.39-4.71) versus 0.29 (0.52-4.05) in the low weight gain group (p=0.008). Nevertheless, other clinical parameters during first manifestation and follow-up were not relevantly different. CONCLUSION: In contrast to the data of children with idiopathic nephrotic syndrome or IgA nephropathy, this study does neither provide evidence for an association between low birth weight nor early weight gain and the later course of PSHN. Interestingly, early weight gain was associated with a higher systolic blood pressure during the initial manifestation of PSHN.


Assuntos
Retardo do Crescimento Fetal/diagnóstico , Vasculite por IgA/diagnóstico , Recém-Nascido de Baixo Peso , Doenças do Prematuro/diagnóstico , Nefrite/diagnóstico , Aumento de Peso , Biópsia , Criança , Pré-Escolar , Ciclofosfamida/efeitos adversos , Ciclofosfamida/uso terapêutico , Feminino , Seguimentos , Taxa de Filtração Glomerular/fisiologia , Humanos , Hipertensão Renal/diagnóstico , Hipertensão Renal/tratamento farmacológico , Vasculite por IgA/tratamento farmacológico , Vasculite por IgA/parasitologia , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Lactente , Recém-Nascido , Doenças do Prematuro/tratamento farmacológico , Doenças do Prematuro/patologia , Rim/patologia , Testes de Função Renal , Masculino , Nefrite/tratamento farmacológico , Nefrite/patologia , Gravidez , Prognóstico , Estudos Retrospectivos
3.
Trans R Soc Trop Med Hyg ; 101(10): 1045-7, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17588627

RESUMO

We describe a 67-year-old Japanese woman who contracted severe falciparum malaria in sub-Saharan Africa. The patient had impaired consciousness, jaundice and acute renal failure. Most interestingly, she manifested purpura fulminans, a cutaneous sign of disseminated intravascular coagulation, which rarely develops in severe falciparum malaria. She required intensive treatment, including haemofiltration, plasma exchange and digital amputation, to recover. This case provides further evidence that purpura fulminans is a potential clinical manifestation of severe falciparum malaria.


Assuntos
Vasculite por IgA/parasitologia , Malária Falciparum/complicações , Viagem , Idoso , Amputação Cirúrgica , Transfusão Total/métodos , Feminino , Humanos , Vasculite por IgA/terapia , Resultado do Tratamento
6.
Acta Paediatr Jpn ; 40(5): 489-91, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9821714

RESUMO

The pathogenesis of Henoch Schönlein purpura (HSP) is unknown but is believed to result from an immune complex reaction to various antigenic stimuli, such as infectious agents. However, its association with Entamoeba histolytica has not been reported before. We present an 11-year-old boy with HSP, confirmed by the demonstration of leukocytoclastic vasculitis from skin and diffuse endocapillary proliferative glomerulonephritis, together with immunoglobulin A and complement component C3 deposition from renal biopsies. Cysts and trophozoites of Entamoeba histolytica were detected from the stool of the patient at the same time and disappeared after the treatment with metranidasole. The temporal association of these two disorders is either coincidental or due to a causal relationship between them.


Assuntos
Entamebíase/complicações , Vasculite por IgA/parasitologia , Animais , Anti-Infecciosos/uso terapêutico , Criança , Entamoeba histolytica/isolamento & purificação , Entamebíase/diagnóstico , Entamebíase/tratamento farmacológico , Fezes/parasitologia , Humanos , Vasculite por IgA/tratamento farmacológico , Vasculite por IgA/etiologia , Masculino , Metronidazol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA